CoChat

Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1

Open access
Lee, Wen-Ying, Lee, Wai-Theng, Cheng, Chia-Hsiung, Chen, Ku-Chung, Chou, Chih-Ming, Chung, Chu-Hung, Sun, Min-Siou, Cheng, Hung-Wei, Ho, Meng-Ni, Lin, Cheng-Wei · 2015 · Oncotarget
Cited by 58

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Wen-Ying Lee 1, 2 , Wai-Theng Lee 3 , Chia-Hsiung Cheng 3, 4 , Ku-Chung Chen 3, 4 , Chih-Ming Chou 3, 4 , Chu-Hung Chung 5 , Min-Siou Sun 5 , Hung-Wei Cheng 3 , Meng-Ni Ho 3 , Cheng-Wei Lin 3, 4 1 Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan 2 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 3 Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 4 Graduate Institute of Medical Sciences, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 5 Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan Correspondence to: Cheng-Wei Lin, e-mail: cwlin@tmu.edu.tw Keywords: chlorpromazine, drug reposition, p53, apoptosis, SIRT1 Received: May 04, 2015 Accepted: August 24, 2015 Published: September 05, 2015 ABSTRACT Investigating existing drugs for repositioning can enable overcoming bottlenecks in the drug development process. Here, we investigated the effect and molecular mechanism of the antipsychotic drug chlorpromazine (CPZ) and identified its potential for treating colorectal cancer (CRC). Human CRC cell lines harboring different p53 statuses were used to investigate the inhibitory mechanism of CPZ. CPZ effectively inhibited tumor growth and induced apoptosis in CRC cells in a p53-dependent manner. Activation of c-jun N-terminal kinase (JNK) was crucial for CPZ-induced p53 expression and the subsequent induction of tumor apoptosis. Induction of p53 acetylation at lysine382 was involved in CPZ-mediated tumor apoptosis, and this induction was attenuated by sirtuin 1 (SIRT1), a class III histone deacetylase. By contrast, knocking down SIRT1 sensitized tumor cells to CPZ treatment. Moreover, CPZ induced the degradation of SIRT1 protein participating downstream of JNK, and JNK suppression abrogated CPZ-mediated SIRT1 downregulation. Clinical analysis revealed a significant association between high SIRT1 expression and poor outcome in CRC patients. These data suggest that SIRT1 is an attractive therapeutic target for CRC and that CPZ is a potential repositioned drug for treating CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4768

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 58

Metadata

Authors
Lee, W.-Y., Lee, W.-T., Cheng, C.-H., Chen, K.-C., Chou, C.-M., Chung, C.-H., Sun, M.-S., Cheng, H.-W., Ho, M.-N., & Lin, C.-W.
Venue
Oncotarget
Published
2015-09-05
Volume
6
Issue
29
Pages
27580-27595
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2265260642
Cited by
58
References
7
FWCI
2.28
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1. https://app.cochat.ai/papers/10.18632/oncotarget.4768
The paper
Lee, W.-Y., Lee, W.-T., Cheng, C.-H., Chen, K.-C., Chou, C.-M., Chung, C.-H., Sun, M.-S., Cheng, H.-W., Ho, M.-N., & Lin, C.-W. (2015). Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1. Oncotarget. https://doi.org/10.18632/oncotarget.4768

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.